ATE271129T1 - Isoliertes p27 protein und nukleinsäure dafür kodierend - Google Patents

Isoliertes p27 protein und nukleinsäure dafür kodierend

Info

Publication number
ATE271129T1
ATE271129T1 AT95906793T AT95906793T ATE271129T1 AT E271129 T1 ATE271129 T1 AT E271129T1 AT 95906793 T AT95906793 T AT 95906793T AT 95906793 T AT95906793 T AT 95906793T AT E271129 T1 ATE271129 T1 AT E271129T1
Authority
AT
Austria
Prior art keywords
protein
subject invention
nucleic acid
isolated
cyclin
Prior art date
Application number
AT95906793T
Other languages
English (en)
Inventor
Joah Massague
James M Roberts
Andrew Koff
Kornelia Polyak
Original Assignee
Sloan Kettering Inst Cancer
Hutchinson Fred Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Inst Cancer, Hutchinson Fred Cancer Res filed Critical Sloan Kettering Inst Cancer
Application granted granted Critical
Publication of ATE271129T1 publication Critical patent/ATE271129T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT95906793T 1994-01-07 1995-01-09 Isoliertes p27 protein und nukleinsäure dafür kodierend ATE271129T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17904594A 1994-01-07 1994-01-07
US08/275,983 US5688665A (en) 1994-01-07 1994-07-15 Isolated nucleic acid molecules encoding the p27 KIP-1 protein
PCT/US1995/000247 WO1995018824A1 (en) 1994-01-07 1995-01-09 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES

Publications (1)

Publication Number Publication Date
ATE271129T1 true ATE271129T1 (de) 2004-07-15

Family

ID=26874941

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95906793T ATE271129T1 (de) 1994-01-07 1995-01-09 Isoliertes p27 protein und nukleinsäure dafür kodierend

Country Status (8)

Country Link
US (1) US5688665A (de)
EP (1) EP0749442B1 (de)
JP (1) JP4143119B2 (de)
AT (1) ATE271129T1 (de)
AU (1) AU699969B2 (de)
CA (1) CA2180570C (de)
DE (1) DE69533255T2 (de)
WO (1) WO1995018824A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242575B1 (en) 1994-01-07 2001-06-05 Fred Hutchinson Institute For Cancer Research Antibodies for detecting p27 protein
US6316208B1 (en) * 1994-01-07 2001-11-13 Memorial Sloan-Kettering Cancer Center Methods for determining isolated p27 protein levels and uses thereof
US6355774B1 (en) 1994-01-07 2002-03-12 Fred Hutchinson Cancer Research Center Isolated p27 protein
AU2770695A (en) 1994-07-15 1996-02-16 Fred Hutchinson Cancer Research Center Isolated p27 protein and methods for its production and use
AU5297496A (en) * 1995-02-17 1996-09-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods of preparation and use of recombinant adenoviral vectors
US7087582B1 (en) 1995-09-26 2006-08-08 Regents Of The University Of Michigan Combination for site-specifically transforming cells in vivo comprising a double-balloon catheter and nucleic acid comprising a gene encoding P21
US5863904A (en) 1995-09-26 1999-01-26 The University Of Michigan Methods for treating cancers and restenosis with P21
WO1997012900A2 (en) * 1995-09-29 1997-04-10 Ciba-Geigy Ag Ring finger protein
EP0877796A4 (de) 1996-01-18 2002-01-02 Hutchinson Fred Cancer Res Zusammensetzungen und verfahren zur vermittlung der fortschrittes des zellzyklus
US6180333B1 (en) * 1997-05-15 2001-01-30 Thomas Jefferson University Determination of cyclin-dependent kinase inhibitor P27 levels as a prognostic factor in cancer patients
US6177272B1 (en) * 1997-07-21 2001-01-23 The Regents Of The University Of Michigan Method for treating vascular proliferative diseases with p27 and fusions thereof
WO1999008700A1 (en) * 1997-08-21 1999-02-25 Thomas Jefferson University pRb2/p130 PEPTIDE INHIBITORS OF cdk2 KINASE ACTIVITY
WO1999028749A1 (en) * 1997-12-01 1999-06-10 Sloan-Kettering Institute For Cancer Research USES OF p27 IN PROSTATE CANCER
US6972170B1 (en) * 1997-12-01 2005-12-06 Sloan-Kettering Institute For Cancer Research Markers for prostate cancer
US6479487B1 (en) * 1998-02-26 2002-11-12 Aventis Pharmaceuticals Inc. 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
US6413974B1 (en) * 1998-02-26 2002-07-02 Aventis Pharmaceuticals Inc. 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
US5973119A (en) * 1998-06-05 1999-10-26 Amgen Inc. Cyclin E genes and proteins
CA2331382A1 (en) * 1998-06-18 1999-12-23 Curagen Corporation Interaction of p27(kip1) with fkbp-12
US6589505B1 (en) 1999-01-29 2003-07-08 St. Jude Children's Research Hospital Cells that lack p19ink4d and p27kip1 activity and methods of use thereof
JP2002543823A (ja) 1999-05-14 2002-12-24 フレッド ハッチンソン キャンサー リサーチ センター 植物サイクリンインヒビター遺伝子を機能的に阻害することによって植物細胞増殖を増加するための方法
EP1512755A3 (de) * 1999-06-10 2007-11-21 Sloan-Kettering Institute For Cancer Research Marker für Prostatakrebs
AU783935B2 (en) * 1999-06-18 2006-01-05 Indiana University Research And Technology Corporation Cardiomyocytes with enhanced proliferative potential, and methods for preparing and using same
WO2002076195A1 (en) * 2001-03-26 2002-10-03 University Of South Florida Ras p27 animal models and uses thereof
GB0117600D0 (en) * 2001-07-19 2001-09-12 Trikon Holdings Ltd Semiconductor structure
US7601299B2 (en) * 2004-06-18 2009-10-13 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US20080053911A1 (en) * 2006-08-30 2008-03-06 Qiagen Gmbh Separation of an organic phase from a mixture comprising organic and aqueous phases by solid phase systems
WO2015120458A1 (en) 2014-02-10 2015-08-13 Fred Hutchinson Cancer Research Center Halogen treatment of heart attack and ischemic injury

Also Published As

Publication number Publication date
JP4143119B2 (ja) 2008-09-03
EP0749442A4 (de) 2000-06-28
DE69533255T2 (de) 2005-07-28
DE69533255D1 (de) 2004-08-19
US5688665A (en) 1997-11-18
AU699969B2 (en) 1998-12-17
CA2180570A1 (en) 1995-07-13
CA2180570C (en) 2002-03-26
EP0749442A1 (de) 1996-12-27
JPH09509311A (ja) 1997-09-22
EP0749442B1 (de) 2004-07-14
WO1995018824A1 (en) 1995-07-13
AU1525195A (en) 1995-08-01

Similar Documents

Publication Publication Date Title
EP0749442A4 (de) ISOLIERTES p27 PROTEIN UND NUKLEINSÄURE DAFÜR KODIEREND
WO1999055868A3 (en) Fizz proteins
ATE310090T1 (de) Gereinigte coprinus laccasen und nukleinsäuren welche dafür kodieren
ATE184052T1 (de) Gdf-1 und uog1 proteine
IL123189A0 (en) Colon cell and colon cancer cell associated nucleic acid molecules protein and peptides
ATE318905T1 (de) Homologe des tie-rezeptortyrosinekinase liganden
SE9201331D0 (sv) Protein l och hybridproteiner daerav
DE69433690D1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
AU6724794A (en) GRB3-3 gene, its variants and their uses
WO1991011462A3 (en) Merosin, nucleic acids encoding, fragments and uses thereof
WO1995008628A3 (en) Nucleic acids encoding merosin, merosin fragments and uses thereof
EP0815240A4 (de) Neue menschliche proteine, die cyclinebhängigen kinasen ähneln, sowie methoden zu deren verwendung
AUPP627498A0 (en) Novel peptides - i
WO1990007000A3 (en) Nucleotides encoding human b1, 4-galactosyltransferase and uses thereof
CA2112701A1 (en) Proteins s polypeptides and uses thereof
IL139272A0 (en) New peptide fragments for protein purification
KR930023459A (ko) 유전분체 전구체 돌연변이 단백질을 암호하는 핵산분자, 이를 포함하는 벡터 및 세포, 이에 의해 생산되는 재조합 폴리펩티드 및 폴리펩티드의 존재를 탐지하는 방법
NZ510812A (en) Novel peptides
Bergstrom et al. DNA encoding borrelia burgdorferi ospa and a method for diagnosing borrelia burgdorferi infection
WO2001046412A3 (de) Interaktionsprotein für stat transkriptionsfaktor
WO2002068648A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these humans ras-like proteins, and uses thereof
WO2001049722A3 (en) New actinobacillus pleuropneumoniae outer membrane protein and its uses
WO2000031125A3 (de) REGULATORISCHES PROTEIN pKe#83 AUS HUMANEN KERATINOZYTEN
WO1999054449A3 (de) Dyskerin und dafür codierende dna-moleküle, diese enthaltende vektoren, antikörper gegen dyskerin und die verwendung dieser gegenstände
WO2002061088A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties